XML 124 R106.htm IDEA: XBRL DOCUMENT v2.4.0.6
Schedule 1 - Condensed Financial Information of Registrant Orthofix International NV - Condensed Statement of Cash Flows (Detail) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Condensed Financial Statements, Captions [Line Items]      
Net income (loss) $ 51,295 $ (1,073) $ 44,208
Cash flows from investing activities:      
Capital expenditures (27,994) (24,965) (25,844)
Cash flows from financing activities:      
Net proceeds from issuance of common stock 25,586 20,113 7,854
Contributions to subsidiaries and affiliates   (517)  
Tax benefit on exercise of stock options   1,737 2,222
Cash and cash equivalents at the beginning of the year 33,207 13,561 13,328
Cash and cash equivalents at the end of the year 31,055 33,207 13,561
Orthofix International N V [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net income (loss) 51,295 (1,073) 44,208
Equity in earnings of investments in subsidiaries and affiliates (59,264) (11,111) (59,620)
Cash used in other operating activities (5,312) 3,799 7,497
Net cash used in operating activities (13,281) (8,385) (7,915)
Cash flows from investing activities:      
Distributions and amounts received from subsidiaries 12,564 5,875 21,597
Capital expenditures     (5)
Net cash provided by investing activities 12,564 5,875 21,592
Cash flows from financing activities:      
Net proceeds from issuance of common stock 25,586 20,113 7,854
Contributions to subsidiaries and affiliates (36,921) (2,789) (21,274)
Tax benefit on exercise of stock options   1,737 2,222
Net cash provided by financing activities (11,335) 19,061 (11,198)
Net increase (decrease) in cash and cash equivalents (12,041) 16,551 2,479
Cash and cash equivalents at the beginning of the year 19,433 2,882 403
Cash and cash equivalents at the end of the year $ 7,392 $ 19,433 $ 2,882